Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma, Unresectable, Advanced”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01079767
What this trial is testing

Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 6
Not applicableLooking for participantsNCT06746194
What this trial is testing

The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ruijin Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00639509
What this trial is testing

IMC-A12 in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Large-scale testing (Phase 3)UnknownNCT03116984
What this trial is testing

Comparison of TACE Combination With and Without EBRT for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Looking for participantsNCT07327034
What this trial is testing

ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 Overexpression

Who this might be right for
Hepatocellular Carcinoma (HCC)
Abbisko Therapeutics Co, Ltd 141
Testing effectiveness (Phase 2)Study completedNCT00077441
What this trial is testing

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 55
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more
Exelixis 1,394
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Early research (Phase 1)Study completedNCT00093444
What this trial is testing

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Who this might be right for
Liver CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 30
Not applicableUnknownNCT02743065
What this trial is testing

HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China

Who this might be right for
Hepatocellular Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 100
Testing effectiveness (Phase 2)Study completedNCT04599777
What this trial is testing

TACE Combined With Sorafenib and Tislelizumab for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 30
Testing effectiveness (Phase 2)Study completedNCT00095992
What this trial is testing

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
NCIC Clinical Trials Group 15
Early research (Phase 1)Study completedNCT00030082
What this trial is testing

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749859
What this trial is testing

SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Unresectable Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)Study completedNCT00875615
What this trial is testing

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Miami 11
Not applicableActive Not RecruitingNCT07669597
What this trial is testing

Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag

Who this might be right for
Locally Advanced or Metastatic Hepatoceullar Carcinoma
Sohag Oncology Center 50
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Study completedNCT01766219
What this trial is testing

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+6 more
Wake Forest University Health Sciences 17
Next Page